Zhao, M., Chen, J., Yuan, Y., Zou, Z., Lai, X., Rahmani, D. M., . . . Bu, S. (2017). Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: A meta-analysis of randomized clinical trials. Nature Portfolio.
Cita Chicago Style (17a ed.)Zhao, Ming, et al. Dipeptidyl Peptidase-4 Inhibitors and Cancer Risk in Patients with Type 2 Diabetes: A Meta-analysis of Randomized Clinical Trials. Nature Portfolio, 2017.
Cita MLA (8a ed.)Zhao, Ming, et al. Dipeptidyl Peptidase-4 Inhibitors and Cancer Risk in Patients with Type 2 Diabetes: A Meta-analysis of Randomized Clinical Trials. Nature Portfolio, 2017.
Precaución: Estas citas no son 100% exactas.